About us
Our Team, Timeline
& Values
Our Team
Our dedicated team of professionals brings unique skills and passion to our work, driving our success and advancing our mission every day.
.jpg)
Chief Executive Officer
The strategic leader driving the overall vision and direction of Silica Corpora.
Chief Scientific Officer
The driving force behind Silica Corpora's scientific innovation.
Chief Technology Officer
The visionary mind behind Silica Corpora's technological advancement.
Scientific Advisor
The scientific expert providing guidance and counselling on scientific matters.
Brand & Marketing Advisor
The branding expert aligning Silica Corpora's goals with its brand image.
Business Development Advisor
The business specialist assisting in the expansion of Silica Corpora's market presence.
Our Timeline
The milestones and significant moments that have shaped our journey.
.png)
September 2022
With the support of the REACT Scholarship from the Startup Incubator Berlin (SIB), Jaime (CEO) and Tim (CSO) transformed their vision into a tangible venture, laying the foundation for Silica Corpora's journey.
Company Formation
March 2023
Silica Corpora celebrated a significant milestone as it successfully completed its Minimum Viable Product (MVP). The platform's ability to generate CDRs from scratch and optimize binding affinity showcases a potential to revolutionize drug design.
First MVP Completion
.png)
October 2023
Accepted into and completed the University of Berkeley SkyDeck's international accelerator program, which includes pre-seed funding award.
Berkeley SkyDeck Accelerator Program
January 2024
Silica Corpora's commitment to innovation was recognised with acceptance into the esteemed Nucleate Activator Program, providing access to expert guidance and resources.
Members of Nucleate Activator Program
.png)
February 2024
Silica Corpora's commitment to innovation was recognised with acceptance into the esteemed Nucleate Activator Program, providing access to expert guidance and resources.
Members of Start2Group
March 2024
Silica Corpora enhanced its strategic framework with the addition of scientific advisors, ready to guide the company through future challenges and opportunities.
Advisors Onboarding
Our Values
These core principles guide our actions and decisions, reflecting who we are and what we stand for.
Reduce, Refine and Replace (3R)
Our DeNovo methods dramatically reduce the need for animal testing. We believe in a future where animal testing is no longer the standard.
3
Remain Sustainable
From the initial stages of research to the final production, we prioritize eco-friendly practices, utilizing green principles to reduce waste and energy consumption. We ensure that our drug development not only advances medical science but also preserves the health of our planet.
4
Democratize Drug Discovery
The Global South has limited autonomy over drug creation and production. We see a world where drug creation and access is available in all countries.
1
2
Remove Cost Barriers
Advancing generative technologies gives us the opportunity to create therapies at the individual level. We see a world where rare diseases and conditions can be treated without worrying about preventative cost-structures.
Our commitment to continuous development is ingrained in every aspect of our organisation, and our commitment is bounded to deliver not only quality in our results, but also to do it through our core values.
At all levels of Silica Corpora, we understand that the journey to success is paved with challenges. If we stumble, we don't stay down—we rise stronger, armed with the lessons learned. We work through respect, and we are keeping the learning growth as a mindset that we apply in all our projects.
- Jaime R.